TABLE 1.
Demographics
| LVH (n=10) | LVH+CHF (n=10) | |
|---|---|---|
| Gender, female:male, n | 6:4 | 5:5 |
| Age, y | 63±10 | 50±10* |
| Body surface area, m2 | 1.9±0.2 | 2.0±0.3 |
| Heart rate, bpm | 71±12 | 76±12 |
| Blood pressure, mm Hg | ||
| Systolic | 143±18 | 145±25 |
| Diastolic | 80±16 | 80±10 |
| Left ventricular mass index, g/m2 | 166±50 | 167±30 |
| Ejection fraction, % | 61±9 | 46±18* |
| Atrial fibrillation, % | 0 | 10 |
| Creatinine, mg/dL | 0.94±0.3 | 1.32±0.5 |
| Diabetes mellitus, % | 50 | 50 |
| History of tobacco use, % | 50 | 70 |
| Current tobacco use, % | 30 | 40 |
| Percentage with use of: | ||
| β-Blocker | 40 | 70 |
| Angiotensin-converting enzyme inhibitor | 60 | 30 |
| Angiotensin receptor blocker | 10 | 0 |
| Loop diuretic | 20 | 60 |
| Spironolactone | 0 | 10 |
| Digoxin | 0 | 0 |
Left ventricular mass index and ejection fraction were determined with echocardiography.
*
P < 0.05.